Abstract
BNP or NT-proBNP testing has dramatically changed the management of acute heart failure patients by aiding in early recognition, prognostication and treatment. Furthermore, recent studies have shown that natriuretic peptide testing may guide the therapy of the stable chronic heart failure patients in out-patient setting. We will review the understanding of utilizing natriuretic peptide testing to guide heart failure therapy, including present and future directions for this exciting area.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Acute Disease
-
Biomarkers / analysis
-
Biomarkers / metabolism
-
Chronic Disease
-
Clinical Trials as Topic
-
Heart Failure / diagnosis*
-
Heart Failure / drug therapy
-
Heart Failure / physiopathology
-
Humans
-
Natriuretic Peptide, Brain / analysis
-
Natriuretic Peptide, Brain / metabolism*
-
Natriuretic Peptides / analysis
-
Natriuretic Peptides / metabolism*
-
Prognosis
Substances
-
Biomarkers
-
Natriuretic Peptides
-
Natriuretic Peptide, Brain